| DICOM PS3.3 2018e - Information Object Definitions |
|---|
Table C.26-1 specifies the Attributes used to convey the characteristics or parameters of a contrast agent, drug, or device.
Table C.26-1. Product Characteristics Module Attributes
|
Identifier of the contrast agent, drug, or device being characterized, typically from a package bar code, RFID, or other materials management ID. This ID might not be globally unique and might conflict with other IDs used within the scope of the institution. |
||
|
For drugs, a coded terminology in the US is RxNorm For devices, a coded terminology in the US is the FDA CDRH Product Code Classification |
||
|
Further description in free form text describing the drug or device. |
||
|
Identifier of the manufacturing batch of which this product is part. |
||
|
The date and time after which the manufacturer no longer ensures the safety, quality, and/or proper functioning of the material. |
||
|
>Include Table 10-2 “Content Item Macro Attributes Description” |
For drugs or contrast agents, for Concept Name Code Sequence, Baseline CID 4050 “Drug or Contrast Agent Characteristics” For devices, for Concept Name Code Sequence, Baseline CID 3423 “Numeric Device Characteristics” |
|
|
Unique identifier for the class of an HL7 Structured Product Label document. |
||
|
Unique identifier for the HL7 Structured Product Label Document as used in DICOM instance references (see Section C.12.1.1.6) |
||
|
Instance Identifier of the referenced HL7 Structured Document, encoded as a UID (OID or UUID), concatenated with a caret ("^") and Extension value (if Extension is present in Instance Identifier). |
||
|
Retrieval access path to Product Label Document. Includes fully specified scheme, authority, path, and query in accordance with [RFC3986] |
||
| DICOM PS3.3 2018e - Information Object Definitions |
|---|